This page shows the latest Hydroxychloroquine news and features for those working in and with pharma, biotech and healthcare.
The interim results, published on the pre-print server medRxiv, showed that remdesivir, along with hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have ‘little or no effect’ on 28-day
Hydroxychloroquine does not work. Ingestion of disinfectants, hand sanitiser and light into the body do not work either.
On 22 May, The Lancet published a research paper about hydroxychloroquine, the antimalarial drug, as a potential treatment for COVID-19. ... claimed that the use of hydroxychloroquine carried a greater risk of heart arrhythmia and death.
The WHO also took the decision to discontinue the Solidarity Trial’s hydroxychloroquine and lopinavir/ritonavir arms following a review of evidence obtained at the interim analysis. ... These results showed that neither hydroxychloroquine nor
This data supports earlier preliminary results from a small study of hydroxychloroquine in combination with the antibiotic azithromycin, and as a monotherapy. ... Although the drug was effective on its own, when added to the antibiotic azithromycin,
The drug, hydroxychloroquine, as well as a related drug, chloroquine, are currently being evaluated for use against COVID-19 in clinical trials around the world. ... Hydroxychloroquine is a derivative of chloroquine, and is less toxic form of the latter
More from news
Approximately 1 fully matching, plus 7 partially matching documents found.
that halted hydroxychloroquine trials due to data inconsistencies, if repeated in the context of SARS-CoV-2 vaccines, risk undermining public confidence in vaccines.
Other antivirals including hydroxychloroquine – a drug championed by President Donald Trump – and favipiravir are also in clinical development, raising hopes that researchers will find a drug with some level of efficacy
A standard malaria treatment: chloroquine and hydroxychloroquine. A decades-old antimalaria drug, chloroquine, entered the global spotlight in March after US President Donald Trump touted it as a potentially effective coronavirus ... treatment. Since then
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Our goal is to identify and embed transformational patient insights as a fundamental part of the drug development process. As...